Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check19 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check26 days agoChange DetectedThe page has updated the number of study locations from 66 to 67 and added a new recruiting entity in Monterrey, Mexico. Additionally, the revision number has been updated from v2.16.4 to v2.16.5.SummaryDifference2%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1.0%
- Check47 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.